PharmD Degree Program

Phillips leads national study of benefit/risk in emergent whole genome sequencing

Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. Indeed, the era of the $1,000 genome—a catchphrase for the test’s relative affordability—appears imminent.

Abate receives NSF CAREER award

Physicist Adam Abate, PhD, who applies microfluidics technology to speedily process millions of encapsulated biological samples to discover drugs, engineer proteins, and diagnose cancers, has received a National Science Foundation (NSF) CAREER award.

Ryan Hernandez awarded Sloan Research Fellowship

Ryan Hernandez, PhD, whose lab studies patterns of genetic variation from populations around the world, using detailed computer modeling to learn more about human evolutionary processes and to discover regions of the genome vital to function and underlying disease, has been named a 2013 Alfred P.

Study finds tobacco control efforts yield huge health care savings

California tobacco control efforts that cost $2.4 billion over nearly two decades reduced health care costs during that same period by $134 billion, according to a new study co-authored by UCSF School of Pharmacy faculty member James Lightwood, PhD.

School to train Safeway pharmacists in smoking cessation counseling

Faculty of the UCSF School of Pharmacy will train Safeway supermarket pharmacists to help their customers quit smoking, using a curriculum originally developed at the School.

The new partnership with Safeway Inc. marks the first time a smoking cessation intervention has been applied systematically...

Benet wins Ebert Prize

During his illustrious half-century career, UCSF School of Pharmacy faculty member Leslie Benet, PhD, has authored more than 400 peer-reviewed publications, many helping to define the field of pharmacokinetics—how the body a

Study finds Medicaid drug selection COI policies vary, may be inadequate

How well do states’ policies address possible conflicts of interest of committee members who decide which drugs get Medicaid reimbursement? The question looms especially large as impending federal health care reform increases the number of patients covered by the state-run drug formularies.

Update from the Dean - Winter 2013

Top NIH funding: Shu, Aweeka, Brodsky. Recent gifts to The Kidney Project. Honors and awards: Day, Youmans, Benet, Schoenhaus. New pharmacy care model, Safeway. John Craig remembered. Mary Anne Koda-Kimble celebrated. Achieving our vision: 2007-2012.

Kidney Project receives two major gifts, increased Hind professorship endowment

Research at the UCSF School of Pharmacy to develop the first implantable bioartificial kidney recently received exceptional private support: $1 million from the family of the late philanthropists Harry and Diana Hind, and $50,000 from the Patterson Barclay Memorial Foundation.

New review finds drug, device study results affected by funding source

An updated and expanded review of clinical research papers on drugs and medical devices finds that industry-sponsored studies are more likely to lead to favorable results, including reports of greater benefits and fewer harmful side effects.

Pages